These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

439 related articles for article (PubMed ID: 30608433)

  • 21. Radiogenomic Models Using Machine Learning Techniques to Predict EGFR Mutations in Non-Small Cell Lung Cancer.
    Nair JKR; Saeed UA; McDougall CC; Sabri A; Kovacina B; Raidu BVS; Khokhar RA; Probst S; Hirsh V; Chankowsky J; Van Kempen LC; Taylor J
    Can Assoc Radiol J; 2021 Feb; 72(1):109-119. PubMed ID: 32063026
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Application of radiomics captured from CT to predict the EGFR mutation status and TKIs therapeutic sensitivity of advanced lung adenocarcinoma].
    Yang CS; Chen WD; Gong GZ; Li ZJ; Qiu QT; Yin Y
    Zhonghua Zhong Liu Za Zhi; 2019 Apr; 41(4):282-287. PubMed ID: 31014053
    [No Abstract]   [Full Text] [Related]  

  • 23. Using Multi-phase CT Radiomics Features to Predict EGFR Mutation Status in Lung Adenocarcinoma Patients.
    Zhang G; Man Q; Shang L; Zhang J; Cao Y; Li S; Qian R; Ren J; Pu H; Zhou J; Zhang Z; Kong W
    Acad Radiol; 2024 Jun; 31(6):2591-2600. PubMed ID: 38290884
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Radiomics for the prediction of EGFR mutation subtypes in non-small cell lung cancer.
    Li S; Ding C; Zhang H; Song J; Wu L
    Med Phys; 2019 Oct; 46(10):4545-4552. PubMed ID: 31376283
    [TBL] [Abstract][Full Text] [Related]  

  • 25. CT imaging-based histogram features for prediction of EGFR mutation status of bone metastases in patients with primary lung adenocarcinoma.
    Shen TX; Liu L; Li WH; Fu P; Xu K; Jiang YQ; Pan F; Guo Y; Zhang MC
    Cancer Imaging; 2019 Jun; 19(1):34. PubMed ID: 31174617
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Genomics of non-small cell lung cancer (NSCLC): Association between CT-based imaging features and EGFR and K-RAS mutations in 122 patients-An external validation.
    Rizzo S; Raimondi S; de Jong EEC; van Elmpt W; De Piano F; Petrella F; Bagnardi V; Jochems A; Bellomi M; Dingemans AM; Lambin P
    Eur J Radiol; 2019 Jan; 110():148-155. PubMed ID: 30599853
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Value of CT features for predicting EGFR mutations and ALK positivity in patients with lung adenocarcinoma.
    Han X; Fan J; Li Y; Cao Y; Gu J; Jia X; Wang Y; Shi H
    Sci Rep; 2021 Mar; 11(1):5679. PubMed ID: 33707479
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Value of
    Lv Z; Fan J; Xu J; Wu F; Huang Q; Guo M; Liao T; Liu S; Lan X; Liao S; Geng W; Jin Y
    Eur J Nucl Med Mol Imaging; 2018 May; 45(5):735-750. PubMed ID: 29164298
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Prognostic and predictive value of interstitial lung abnormalities and EGFR mutation status in patients with non-small cell lung cancer.
    Xu X; Zhu M; Wang Z; Li J; Ouyang T; Chen C; Huang K; Zhang Y; Gao YL
    Cancer Imaging; 2024 May; 24(1):66. PubMed ID: 38783331
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Distinguishing EGFR mutation molecular subtypes based on MRI radiomics features of lung adenocarcinoma brain metastases.
    Xu J; Yang Y; Gao Z; Song T; Ma Y; Yu X; Shi C
    Clin Neurol Neurosurg; 2024 May; 240():108258. PubMed ID: 38552362
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Hybrid deep multi-task learning radiomics approach for predicting EGFR mutation status of non-small cell lung cancer in CT images.
    Gong J; Fu F; Ma X; Wang T; Ma X; You C; Zhang Y; Peng W; Chen H; Gu Y
    Phys Med Biol; 2023 Dec; 68(24):. PubMed ID: 37972417
    [No Abstract]   [Full Text] [Related]  

  • 32. Current progress and quality of radiomic studies for predicting EGFR mutation in patients with non-small cell lung cancer using PET/CT images: a systematic review.
    Abdurixiti M; Nijiati M; Shen R; Ya Q; Abuduxiku N; Nijiati M
    Br J Radiol; 2021 Jun; 94(1122):20201272. PubMed ID: 33882244
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Associations Between Somatic Mutations and Metabolic Imaging Phenotypes in Non-Small Cell Lung Cancer.
    Yip SS; Kim J; Coroller TP; Parmar C; Velazquez ER; Huynh E; Mak RH; Aerts HJ
    J Nucl Med; 2017 Apr; 58(4):569-576. PubMed ID: 27688480
    [TBL] [Abstract][Full Text] [Related]  

  • 34. CT radiomics-based model for predicting TMB and immunotherapy response in non-small cell lung cancer.
    Wang J; Wang J; Huang X; Zhou Y; Qi J; Sun X; Nie J; Hu Z; Wang S; Hong B; Wang H
    BMC Med Imaging; 2024 Feb; 24(1):45. PubMed ID: 38360550
    [TBL] [Abstract][Full Text] [Related]  

  • 35. CT features associated with EGFR mutations and ALK positivity in patients with multiple primary lung adenocarcinomas.
    Han X; Fan J; Gu J; Li Y; Yang M; Liu T; Li N; Zeng W; Shi H
    Cancer Imaging; 2020 Jul; 20(1):51. PubMed ID: 32690092
    [TBL] [Abstract][Full Text] [Related]  

  • 36. EGFR Mutation Status and Subtypes Predicted by CT-Based 3D Radiomic Features in Lung Adenocarcinoma.
    Chen Q; Li Y; Cheng Q; Van Valkenburgh J; Sun X; Zheng C; Zhang R; Yuan R
    Onco Targets Ther; 2022; 15():597-608. PubMed ID: 35669165
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Combination of
    Li S; Li Y; Zhao M; Wang P; Xin J
    Korean J Radiol; 2022 Sep; 23(9):921-930. PubMed ID: 36047542
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Cone-beam CT radiomics features might improve the prediction of lung toxicity after SBRT in stage I NSCLC patients.
    Qin Q; Shi A; Zhang R; Wen Q; Niu T; Chen J; Qiu Q; Wan Y; Sun X; Xing L
    Thorac Cancer; 2020 Apr; 11(4):964-972. PubMed ID: 32061061
    [TBL] [Abstract][Full Text] [Related]  

  • 39. CT-based non-invasive identification of the most common gene mutation status in patients with non-small cell lung cancer.
    Chen Z; Gao S; Ding C; Luo T; Xu J; Xu S; Li S
    Med Phys; 2024 Mar; 51(3):1872-1882. PubMed ID: 37706584
    [TBL] [Abstract][Full Text] [Related]  

  • 40. 18F-FDG uptake for prediction EGFR mutation status in non-small cell lung cancer.
    Guan J; Xiao NJ; Chen M; Zhou WL; Zhang YW; Wang S; Dai YM; Li L; Zhang Y; Li QY; Li XZ; Yang M; Wu HB; Chen LH; Liu LY
    Medicine (Baltimore); 2016 Jul; 95(30):e4421. PubMed ID: 27472739
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 22.